These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1400458)
41. Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase. Meyer PR; Matsuura SE; Zonarich D; Chopra RR; Pendarvis E; Bazmi HZ; Mellors JW; Scott WA J Virol; 2003 Jun; 77(11):6127-37. PubMed ID: 12743270 [TBL] [Abstract][Full Text] [Related]
42. Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site. Klarmann GJ; Smith RA; Schinazi RF; North TW; Preston BD J Biol Chem; 2000 Jan; 275(1):359-66. PubMed ID: 10617626 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate. Mazumder A; Cooney D; Agbaria R; Gupta M; Pommier Y Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5771-5. PubMed ID: 8016063 [TBL] [Abstract][Full Text] [Related]
44. Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. McKee EE; Bentley AT; Hatch M; Gingerich J; Susan-Resiga D Cardiovasc Toxicol; 2004; 4(2):155-67. PubMed ID: 15371631 [TBL] [Abstract][Full Text] [Related]
45. Metabolism of 4'-azidothymidine. A compound with potent and selective activity against the human immunodeficiency virus. Chen MS; Suttmann RT; Wu JC; Prisbe EJ J Biol Chem; 1992 Jan; 267(1):257-60. PubMed ID: 1730594 [TBL] [Abstract][Full Text] [Related]
46. Gamma-phosphate-substituted 2'-deoxynucleoside 5'-triphosphates as substrates for DNA polymerases. Arzumanov AA; Semizarov DG; Victorova LS; Dyatkina NB; Krayevsky AA J Biol Chem; 1996 Oct; 271(40):24389-94. PubMed ID: 8798694 [TBL] [Abstract][Full Text] [Related]
48. 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. St Clair MH; Richards CA; Spector T; Weinhold KJ; Miller WH; Langlois AJ; Furman PA Antimicrob Agents Chemother; 1987 Dec; 31(12):1972-7. PubMed ID: 2449866 [TBL] [Abstract][Full Text] [Related]
49. The Y181C substitution in 3'-azido-3'-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer. Selmi B; Deval J; Alvarez K; Boretto J; Sarfati S; Guerreiro C; Canard B J Biol Chem; 2003 Oct; 278(42):40464-72. PubMed ID: 12902345 [TBL] [Abstract][Full Text] [Related]
50. Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues. Matamoros T; Deval J; Guerreiro C; Mulard L; Canard B; Menéndez-Arias L J Mol Biol; 2005 Jun; 349(3):451-63. PubMed ID: 15878178 [TBL] [Abstract][Full Text] [Related]
51. Selective action of 2',3'-didehydro-2',3'-dideoxythymidine triphosphate on human immunodeficiency virus reverse transcriptase and human DNA polymerases. Huang P; Farquhar D; Plunkett W J Biol Chem; 1992 Feb; 267(4):2817-22. PubMed ID: 1370834 [TBL] [Abstract][Full Text] [Related]
52. Low-dose, sublingual AZT-monophosphate therapy for HIV+ patients? Johnson S Med Hypotheses; 2001 Mar; 56(3):409-10. PubMed ID: 11359372 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases. White EL; Parker WB; Macy LJ; Shaddix SC; McCaleb G; Secrist JA; Vince R; Shannon WM Biochem Biophys Res Commun; 1989 Jun; 161(2):393-8. PubMed ID: 2472136 [TBL] [Abstract][Full Text] [Related]
54. Fidelity studies of the human DNA polymerase alpha. The most conserved region among alpha-like DNA polymerases is responsible for metal-induced infidelity in DNA synthesis. Copeland WC; Lam NK; Wang TS J Biol Chem; 1993 May; 268(15):11041-9. PubMed ID: 8496165 [TBL] [Abstract][Full Text] [Related]
55. Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates. Ueno T; Shirasaka T; Mitsuya H J Biol Chem; 1995 Oct; 270(40):23605-11. PubMed ID: 7559526 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Merta A; Votruba I; Rosenberg I; Otmar M; Hrebabecký H; Bernaerts R; Holý A Antiviral Res; 1990 May; 13(5):209-18. PubMed ID: 2168689 [TBL] [Abstract][Full Text] [Related]
57. Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog. Paintsil E; Dutschman GE; Hu R; Grill SP; Lam W; Baba M; Tanaka H; Cheng YC Antimicrob Agents Chemother; 2007 Nov; 51(11):3870-9. PubMed ID: 17724147 [TBL] [Abstract][Full Text] [Related]
58. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection. Avramis VI; Kwock R; Solorzano MM; Gomperts E J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464 [TBL] [Abstract][Full Text] [Related]
59. Stereospecificity of human DNA polymerases alpha, beta, gamma, delta and epsilon, HIV-reverse transcriptase, HSV-1 DNA polymerase, calf thymus terminal transferase and Escherichia coli DNA polymerase I in recognizing D- and L-thymidine 5'-triphosphate as substrate. Focher F; Maga G; Bendiscioli A; Capobianco M; Colonna F; Garbesi A; Spadari S Nucleic Acids Res; 1995 Aug; 23(15):2840-7. PubMed ID: 7544886 [TBL] [Abstract][Full Text] [Related]
60. Studies of neutralizing monoclonal antibody to human immunodeficiency virus type 1 reverse transcriptase: antagonistic and synergistic effects in reactions performed in the presence of nucleoside and nonnucleoside inhibitors, respectively. Gu Z; Li X; Quan Y; Parniak MA; Wainberg MA J Virol; 1996 Apr; 70(4):2620-6. PubMed ID: 8642696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]